Predemtec GmbH
Hennigsdorf
About Predemtec GmbH
Predemtec focuses on the research, development, and manufacture of diagnostic tests to determine risk factors for dementia and other illnesses. Its DX test is a serum-based immunoassay used for early detection and risk diagnosis of senile dementia of the Alzheimer’s type. Predemtec was founded in 2011 by Annegret Feuerhelm-Heidl.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jul 2014)
- Website: predemtecdx.com
- Phone: +49 3302 2021602
Industries & Categories
Biotechnology, Developer Tools, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/predemtec-gmbh-3141294 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.